Improved outcomes after hypothermic oxygenated machine perfusion in liver transplantation-Long-term follow-up of a multicenter randomized controlled trial.

After excluding recipients who died during the initial hospitalization following LT (n=4) and censoring for death related to tumor recurrence (n=3) in a supplementary analysis, the difference in graft survival yielded a marginally nonsignificant result (log-rank p =0.060); however, with a numerically worse outcome for patients who received SCS-treated allografts (HOPE 1.000, 0.952, 0.952 vs.

also in 448 other papers